These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24080339)
21. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer. Seidel C; Schnekenburger M; Mazumder A; Teiten MH; Kirsch G; Dicato M; Diederich M Biochem Pharmacol; 2016 Jan; 99():31-52. PubMed ID: 26549368 [TBL] [Abstract][Full Text] [Related]
22. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. Rahim R; Strobl JS Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological characterization of spiro[2H-(1,3)-benzoxazine-2,4'-piperidine] based histone deacetylase inhibitors. Thaler F; Varasi M; Abate A; Carenzi G; Colombo A; Bigogno C; Boggio R; Zuffo RD; Rapetti D; Resconi A; Regalia N; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C Eur J Med Chem; 2013 Jun; 64():273-84. PubMed ID: 23644210 [TBL] [Abstract][Full Text] [Related]
24. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells. Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193 [TBL] [Abstract][Full Text] [Related]
25. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells. Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175 [TBL] [Abstract][Full Text] [Related]
26. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604 [TBL] [Abstract][Full Text] [Related]
29. Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. Berger A; Venturelli S; Kallnischkies M; Böcker A; Busch C; Weiland T; Noor S; Leischner C; Weiss TS; Lauer UM; Bischoff SC; Bitzer M J Nutr Biochem; 2013 Jun; 24(6):977-85. PubMed ID: 23159065 [TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors in cancer therapy. Lane AA; Chabner BA J Clin Oncol; 2009 Nov; 27(32):5459-68. PubMed ID: 19826124 [TBL] [Abstract][Full Text] [Related]
31. Inhibitors of histone deacetylase as antitumor agents: A critical review. Manal M; Chandrasekar MJ; Gomathi Priya J; Nanjan MJ Bioorg Chem; 2016 Aug; 67():18-42. PubMed ID: 27239721 [TBL] [Abstract][Full Text] [Related]
32. Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu mice. Joung KE; Min KN; An JY; Kim DK; Kong G; Sheen YY Cancer Res; 2006 May; 66(10):5394-402. PubMed ID: 16707467 [TBL] [Abstract][Full Text] [Related]
33. Development of histone deacetylase inhibitors for cancer treatment. Marchion D; Münster P Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177 [TBL] [Abstract][Full Text] [Related]
34. HDAC6 as a target for antileukemic drugs in acute myeloid leukemia. Hackanson B; Rimmele L; Benkißer M; Abdelkarim M; Fliegauf M; Jung M; Lübbert M Leuk Res; 2012 Aug; 36(8):1055-62. PubMed ID: 22464548 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors. Zhu Y; Ran T; Chen X; Niu J; Zhao S; Lu T; Tang W Chem Pharm Bull (Tokyo); 2016; 64(8):1136-41. PubMed ID: 27477652 [TBL] [Abstract][Full Text] [Related]
37. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges. Atadja P Cancer Lett; 2009 Aug; 280(2):233-41. PubMed ID: 19344997 [TBL] [Abstract][Full Text] [Related]
38. Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and histone deacetylase activity. Mahboobi S; Sellmer A; Winkler M; Eichhorn E; Pongratz H; Ciossek T; Baer T; Maier T; Beckers T J Med Chem; 2010 Dec; 53(24):8546-55. PubMed ID: 21080629 [TBL] [Abstract][Full Text] [Related]
39. Histone deacetylases and cancer: causes and therapies. Marks P; Rifkind RA; Richon VM; Breslow R; Miller T; Kelly WK Nat Rev Cancer; 2001 Dec; 1(3):194-202. PubMed ID: 11902574 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors. Li Y; Wang Y; Xie N; Xu M; Qian P; Zhao Y; Li S Eur J Med Chem; 2015 Jul; 100():270-6. PubMed ID: 26140961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]